USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse

MSB had a bad year. Even the iIR type said that on her departure from the 55 Collins Street major shareholder love shack.

So what next?

aGVHD in tatters. But plenty of REM-L in stock .

ARDS - well maybe circa 40% response was too high (notwithstanding posts on the Overwhelming Efficacy HC threads)

CHF - dang missed the primary endpoint but hey there is a diamond in the subsets for the secondary endpoint. How did that happen?

CLBP - tick tock.

Consider this. 4.5b was spent on the large hadron collider. it achieved one of its goals of proving the existence of the Higgs boson.

MSB has spent more than 10% of that and proved nothing that the FDA accepts.

Surely after such a bad 2020, hope can create a better 2021.